Related Experiment Videos
Discovery and structure-function analysis of alpha-melanocyte-stimulating hormone antagonists
C K Jayawickreme1, J M Quillan, G F Graminski
1Department of Internal Medicine, Boyer Center for Molecular Medicine, Yale University School of Medicine, New Haven, Connecticut 06536-0812.
The Journal of Biological Chemistry
|November 25, 1994
Summary
Researchers identified novel alpha-melanocyte-stimulating hormone (alpha-MSH) receptor antagonists by screening a large peptide library. Key structural elements were found to be crucial for blocking alpha-MSH receptor activity.
Area of Science:
- Endocrinology
- Pharmacology
- Medicinal Chemistry
Background:
- Alpha-melanocyte-stimulating hormone (alpha-MSH) plays a critical role in various physiological processes.
- Understanding alpha-MSH receptor interactions is essential for developing targeted therapeutics.
Purpose of the Study:
- To investigate structure-function relationships of alpha-MSH.
- To identify novel alpha-MSH receptor antagonists.
Main Methods:
- Generated a peptide library of 31,360 candidates based on the alpha-MSH-[5-13] sequence.
- Screened approximately 40% of the library for receptor antagonist activity.
- Determined IC50 values and analyzed critical amino acid residues for antagonist potency.
Main Results:
- Identified novel alpha-MSH receptor antagonists with varying potencies.
- The most potent antagonist exhibited an IC50 of 11 +/- 7 nM.
- D-Tryptophan at position 5 and Phenylalanine at position 6 were identified as crucial for antagonistic properties, potentiated by D-Phenylalanine at position 3.
Conclusions:
- Residues in positions 5-6, 7-9, and 10 of the alpha-MSH sequence are critical determinants for potent antagonist activity.
- This study provides insights into the structural requirements for alpha-MSH receptor inactivation.
- Novel antagonists identified offer potential for therapeutic applications targeting alpha-MSH pathways.